Event-Driven Stocks

Lyra Therapeutics, Inc.

LYRAOTC

Healthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 2 good● 5 warning● 2 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$398,000$1.5M$1.6M$1.4M$285,000—
Operating income−$31.0M−$96.3M−$67.1M−$56.3M−$43.6M−$22.2M
Net income−$28.9M−$93.4M−$62.7M−$55.3M−$43.5M−$22.1M
Total assets$36.1M$66.3M$142.6M$110.0M$54.9M$80.8M
Total liabilities$46.8M$54.8M$53.2M$29.2M$20.6M$6.3M
Equity−$10.7M$11.6M$89.4M$80.8M$34.3M$74.5M
EPS (diluted)$-18.62$-71.75$-1.26$-1.83$-3.35—
Shares out.65.9M59.7M31.8M13.0M12.9M12.9M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−7794.5%
Net margin
−7266.1%
Return on equity
269.8%
Return on assets
−80.1%
Return on capital (ROCE)
−116.7%
Liabilities / assets
129.7%
Debt / equity
—
Book value / share
$-0.16
Revenue growth (YoY)
−74.1%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-43.94distress
Accruals / assets
−0.2%clean
Piotroski F-Score
2/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
36
/ 100
Profitability 20Growth 0Catalyst 67Earnings quality 67Financial strength 25

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →

Signs

● 2 severe● 5 warning● 2 good
  • Negative shareholder equity
  • Altman Z″ in the distress zone
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue declined year-over-year
  • High leverage (liabilities > 70% of assets)
  • Negative operating cash flow
  • Strong return on equity (>15%)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 20263,1641.0-0.3%
Apr 30, 20263,1731.0-12.1%
Apr 15, 20263,6101.0-93.7%
Mar 31, 202656,9031.0+33.5%
Mar 13, 202642,6221.0+157.8%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (3)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.